|
|
 | | | |
- close
- close
- close
- close
DUSA Pharmaceuticals (DUSA) |
StreetInsider.com
Dec 14
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/DUSA+Pharma+%28DUSA%29+Reports+Statistically+Significant+Data+from+Kerastick+Phase+2/7950183.html for the full story.
Benzinga
Dec 5
Comment
Caraco
Pharmaceutical Laboratories, Ltd. ("CPL"), a wholly owned subsidiary of Sun
Pharmaceutical Industries Limited ("Sun Pharma"), and DUSA Pharmaceuticals,
Inc. (Nasdaq: DUSA) ("DUSA") today announced that they have received notice
from the...
The Economic Times
Nov 9
Comment
Shares of Sun Pharma moved higher in trade of Friday as sentiment turned bullish after it signed a pact to buy US-based DUSA Pharmaceuticals.
The Hindu Business Line
Nov 8
Comment
Sun Pharmaceutical has entered into an agreement to acquire DUSA, a US-based dermatology company, for about $230 million (over Rs 1,200 crore) in cash. “DUSA’s business brings us an entr...
StreetInsider.com
Nov 8
Comment
Boston Scientific Corporation (NYSE: BSX) is extending its reach into the strategically critical renal denervation market by signing a definitive agreement to acquire Vessix Vascular, Inc., a privately held company based in Laguna Hills,...
StreetInsider.com
Nov 8
Comment
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) 39% LOWER; reported Q3 EPS of ($0.19), $0.02 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $5.8 million versus the consensus estimate of $4.63 million. Evaluating...
FiercePharma
Nov 8
Comment
Dermatology is hot. Valeant Pharmaceuticals ($VRX) has been snapping up skin-remedy companies, including its recent $2.6 billion deal for Medicis. Novartis' generics unit Sandoz agreed in May to buy U.S.-based Fougera Pharmaceuticals, to become...
StreetInsider.com
Sep 13
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/DUSA+Pharma+%28DUSA%29+Reports+Statistically+Significant+Results+from+Levulan+Kerastick+on+Lesion+Reduction/7723920.html for the full story.
Benzinga
Sep 13
Comment
DUSA Pharmaceuticals,
Inc.^® (Nasdaq: DUSA), a dermatology company that is developing and marketing
its Levulan^® (aminolevulinic acid HCl) Photodynamic Therapy (PDT) platform,
today announced results of an investigational study designed to...
StreetInsider.com
Aug 2
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/DUSA+Pharmaceuticals+%28DUSA%29+Reports+In-Line+Q2+EPS+of+6c/7624441.html for the full story.
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS|
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_1/mediawiki/images/9/98/New_stock.png': No such file or directory @ blob.c/OpenBlob/2480. convert: unable to open file `/home/wikinvest/src_live_1/mediawiki/images/9/98/New_stock.png' @ png.c/ReadPNGImage/2889. convert: missing an image filename `/home/wikinvest/src_live_1/mediawiki/images/thumb/9/98/New_stock.png/35px-New_stock.png' @ convert.c/ConvertImageCommand/2800. |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
